Putnam Investments’s CinCor Pharma, Inc. Common Stock CINC Stock Holding History

Putnam Investments’s Portfolio CINC Stock Details CINC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-35,728	Closed	-$439K	–	1240
2022 Q4	$439K	Buy	+35,728	New	+$851K	﹤0.01%	960

Putnam Investments's CINC Position: Q1 2023 in Review

Putnam Investments sold out of CinCor Pharma, Inc. Common Stock (CINC) in Q1 2023, closing a stake of 35,728 shares — an estimated $439K sold.

Putnam Investments first reported a position in CINC in Q4 2022 and held it in 1 quarter. The position peaked at $439K in Q4 2022. 0 funds tracked by Wall St. Rank hold CINC as of Q1 2023.

Putnam Investments reported no remaining CinCor Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
Putnam Investments sold 35,728 CinCor Pharma, Inc. Common Stock shares in Q1 2023, an estimated $439K.
Putnam Investments first reported a position in CinCor Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
Putnam Investments's CinCor Pharma, Inc. Common Stock position peaked at $439K in Q4 2022.
0 funds tracked by Wall St. Rank held CinCor Pharma, Inc. Common Stock as of Q1 2023.

Based on Putnam Investments's 13F filing for Q1 2023, filed 22 May 2023.